Adrenal Tumours
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| National Study of Adrenal Tumours (NCT06870396) | Society for Endocrinology | 2025-01-15 |
| Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). (NCT06607692) | Fundación de investigación HM | 2024-09-20 |
Track Adrenal Tumours automatically
Every clearance here is in the API, with alerts when new ones post.